Serologicals Corporation Authorizes Share Repurchase Plan

Serologicals announced that its board of directors has authorized a stock repurchase program to repurchase up to 2 million shares of the company's common stock over the next three years ending in June 2008. The program is intended to be implemented through purchases made from time to time in the open market or through private transactions in accordance with applicable securities laws. The timing, pricing and size of purchases will depend on market conditions, prevailing stock prices and other considerations. As of June 9, 2005, the company had approximately 35 million shares of common shares outstanding.

()a href="http://home.businesswire.com/portal/site/biospace/index.jsp?epi-content=GENERIC&newsId=20050610005254&ndmHsc=v2*A1117796400000*B1118438379000*DgroupByDate*J2*N1000122&newsLang=en&beanID=1229976837&viewID=news_view" target="_blank">BioSpace